文献
J-GLOBAL ID:200902276566420829
整理番号:07A0386797
新規PI3キナーゼp110α阻害剤としてのピリド[3′,2′:4,5]フロ[3,2-d]ピリミジン誘導体の合成と生物学的評価
Synthesis and biological evaluation of pyrido[3′,2′:4,5]furo[3,2-d]pyrimidine derivatives as novel PI3 kinase p110α inhibitors
著者 (13件):
HAYAKAWA Masahiko
(Drug Discovery Res., Astellas Pharma Inc., 5-2-3 Tokodai, Tsukuba, Ibaraki 300-2698, JPN)
,
KAIZAWA Hiroyuki
(Drug Discovery Res., Astellas Pharma Inc., 5-2-3 Tokodai, Tsukuba, Ibaraki 300-2698, JPN)
,
MORITOMO Hiroyuki
(Drug Discovery Res., Astellas Pharma Inc., 5-2-3 Tokodai, Tsukuba, Ibaraki 300-2698, JPN)
,
KOIZUMI Tomonobu
(Drug Discovery Res., Astellas Pharma Inc., 5-2-3 Tokodai, Tsukuba, Ibaraki 300-2698, JPN)
,
OHISHI Takahide
(Drug Discovery Res., Astellas Pharma Inc., 5-2-3 Tokodai, Tsukuba, Ibaraki 300-2698, JPN)
,
YAMANO Mayumi
(Drug Discovery Res., Astellas Pharma Inc., 5-2-3 Tokodai, Tsukuba, Ibaraki 300-2698, JPN)
,
OKADA Minoru
(Drug Discovery Res., Astellas Pharma Inc., 5-2-3 Tokodai, Tsukuba, Ibaraki 300-2698, JPN)
,
OHTA Mitsuaki
(Drug Discovery Res., Astellas Pharma Inc., 5-2-3 Tokodai, Tsukuba, Ibaraki 300-2698, JPN)
,
TSUKAMOTO Shin-ichi
(Drug Discovery Res., Astellas Pharma Inc., 5-2-3 Tokodai, Tsukuba, Ibaraki 300-2698, JPN)
,
RAYNAUD Florence I.
(Cancer Res. UK Centre for Cancer Therapeutics, The Inst. of Cancer Res., Sutton, Surrey SN2 5NG, GBR)
,
WORKMAN Paul
(Cancer Res. UK Centre for Cancer Therapeutics, The Inst. of Cancer Res., Sutton, Surrey SN2 5NG, GBR)
,
WATERFIELD Michael D.
(Ludwig Inst. for Cancer Res., 91 Riding House Street, London W1W 7BS, GBR)
,
PARKER Peter
(Cancer Res. UK London Res. Inst., 44 Lincoln’s Inn Fields, London WC2A 3PX, GBR)
資料名:
Bioorganic & Medicinal Chemistry Letters
(Bioorganic & Medicinal Chemistry Letters)
巻:
17
号:
9
ページ:
2438-2442
発行年:
2007年05月01日
JST資料番号:
W0248A
ISSN:
0960-894X
資料種別:
逐次刊行物 (A)
発行国:
オランダ (NLD)
言語:
英語 (EN)